A Three-Arm Randomized Controlled Trial of Primary One-Anastomosis Gastric Bypass: With FundoRing or Nissen Fundoplications Vs. Without Fundoplication for the Treatment of Obesity and Gastroesophageal Reflux Disease

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2024 Mar 28

PMID 38541131

Authors

Oral Ospanov

Nurlan Zharov

Bakhtiyar Yelembayev

Galymjan Duysenov

Irina Volchkova

Kassymkhan Sultanov

Adil Mustafin

Affiliations

Soon will be listed here.

Abstract

: Obesity and gastroesophageal reflux disease (GERD) are steadily increasing world weight and antireflux surgery must be performed simultaneously with bariatric surgery in obese patients. The purpose of this study is to compare bariatric and antireflux results after OAGB with different methods of fundoplication using the excluded stomach and without fundoplication. : This open-label, randomized, parallel three-arm trial was conducted from March 2019 and December 2021. All patients underwent laparoscopic one-anastomosis gastric bypass and suture cruroplasty, and then had a follow-up at 24 months. Group 1 of patients had fundoplication FundoRing using the excluded stomach (FundoRingOAGB); Group 2, with Nissen fundoplication using the excluded stomach (NissenOAGB); and Group 3, without fundoplication (OAGB). We studied changes in BMI, GERD symptoms (GERD-HRQL), and the VISICK score. : Of 219 participants screened, 150 were randomly allocated to 3 groups: FundoRingOAGB group ( = 50), NissenOAGB group ( = 50), and OAGB group ( = 50). At post-treatment month 24, BMI changes were as follows: from 40.7 ± 5.9 (31-53) to 24.3 ± 2.8 (19-29) kg/m in FundoRingOAGB group; from 39.9 ± 5.3 (32-54) to 26.3 ± 2.9 (23-32) kg/m in Nissen group; and from 40.9 ± 6.2 (32-56) to 28.5 ± 3.9 (25-34) kg/m in OAGB group. The mean pre-operative GERD-HRQL heartburn score improved post-op in FundoRingOAGB group from 20.6 ± 2.24 (19.96, 21.23) to 0.44 ± 0.73 (0.23, 0,64); in NissenOAGB group from 21.34 ± 2.43 (20.64, 22.03) to 1.14 ± 1.4 (0.74, 1.53); and in OAGB group 20.5 ± 2.17 (19.9, 21.25) to 2.12 ± 1.36 (1.73, 2.5). GERD-HRQL total scores were from pre-op 25.2 ± 2.7 (24.4, 25.9) to 4.34 ± 1.3 (3.96, 4.7) post-op in FundoRingOAGB group; 24.8 ± 2.93 (24, 25.67) pre-op to 5.42 ± 1.7 (4.9, 5.9) in the NissenOAGB group; and from 21.46 ± 2.7 (20.7, 22.2) to 7.44 ± 2.7 (6.6, 8.2) in the OAGB group. The mean VISICK score improved from 3.64 ± 0.94 (3.7, 3.9) to 1.48 ± 1.26 (1.12, 1.84) in FundoRingOAGB, from 3.42 ± 0.97 (3.1, 3,7) to 2.5 ± 1.46 (2.06, 2.9) in NissenOAGB group and from 3.38 ± 0.88 (3.1, 3,69) to 2.96 ± 1.19 (2.62, 3.2) in OAGB group. : Antireflux and bariatric results of FundoRingOAGB are better than using the NissenOAGB method and significantly better than OAGB without the use of fundoplication.

References

Contini S, Zinicola R, Bertele A, Nervi G, Rubini P, Scarpignato C . Dysphagia and clinical outcome after laparoscopic Nissen or Rossetti fundoplication: sequential prospective study. World J Surg. 2002; 26(9):1106-11. DOI: 10.1007/s00268-002-6247-2. View

Soprani A, Boullenois H, Zulian V, Nedelcu A, Carandina S . One-Anastomosis Gastric Bypass and Hiatal Hernia: Nissen Fundoplication with the Excluded Stomach to Decrease the Risk of Postoperative Gastroesophageal Reflux. J Clin Med. 2022; 11(21). PMC: 9655570. DOI: 10.3390/jcm11216441. View

Ferrer-Marquez M, Garcia-Redondo M, Maturana-Ibanez V, Estebanez-Ferrero B, Fernandez-Alonso A, Rubio-Gil F . Bile reflux and marginal ulcers after one-anastomosis gastric bypass (OAGB). A narrative review. Cir Esp (Engl Ed). 2023; 101 Suppl 4:S69-S75. DOI: 10.1016/j.cireng.2023.04.006. View

Martin Del Campo S, Chaudhry U, Kanji A, Suzo A, Perry K . Laparoscopic Nissen fundoplication controls reflux symptoms and improves disease-specific quality of life in patients with class I and II obesity. Surgery. 2017; 162(5):1048-1054. DOI: 10.1016/j.surg.2017.07.006. View

Carbajo M, Luque-de-Leon E, Jimenez J, Ortiz-de-Solorzano J, Perez-Miranda M, Castro-Alija M . Laparoscopic One-Anastomosis Gastric Bypass: Technique, Results, and Long-Term Follow-Up in 1200 Patients. Obes Surg. 2016; 27(5):1153-1167. PMC: 5403902. DOI: 10.1007/s11695-016-2428-1. View

Rubino F, Nathan D, Eckel R, Schauer P, Alberti K, Zimmet P . Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Surg Obes Relat Dis. 2016; 12(6):1144-62. DOI: 10.1016/j.soard.2016.05.018. View

Swartz D, Mobley E, Felix E . Bile reflux after Roux-en-Y gastric bypass: an unrecognized cause of postoperative pain. Surg Obes Relat Dis. 2008; 5(1):27-30. DOI: 10.1016/j.soard.2008.10.009. View

Schietroma M, Piccione F, Clementi M, Cecilia E, Sista F, Pessia B . Short- and Long-Term, 11-22 Years, Results after Laparoscopic Nissen Fundoplication in Obese versus Nonobese Patients. J Obes. 2017; 2017:7589408. PMC: 5444001. DOI: 10.1155/2017/7589408. View

Ospanov O, Maleckas A, Orekeshova A . Gastric greater curvature plication combined with Nissen fundoplication in the treatment of gastroesophageal reflux disease and obesity. Medicina (Kaunas). 2016; 52(5):283-290. DOI: 10.1016/j.medici.2016.08.001. View

10.

Ma P, Higa K . Laparoscopic modified Nissen fundoplication over Roux-en-Y gastric bypass and hiatal hernia repair for intractable gastroesophageal reflux. Surg Obes Relat Dis. 2020; 16(11):1877-1878. DOI: 10.1016/j.soard.2020.06.036. View

11.

Kawahara N, Alster C, Maluf-Filho F, Polara W, Campos G, Poli-de-Figueiredo L . Modified Nissen fundoplication: laparoscopic antireflux surgery after Roux-en-Y gastric bypass for obesity. Clinics (Sao Paulo). 2012; 67(5):531-3. PMC: 3351257. DOI: 10.6061/clinics/2012(05)23. View

12.

Colpaert J, Horevoets J, Maes L, Uijtterhaegen G, Dillemans B . Surgical treatment of therapy-resistant reflux after Roux-en-Y gastric bypass. A case series of the modified Nissen fundoplication. Acta Chir Belg. 2019; 120(4):291-296. DOI: 10.1080/00015458.2019.1696028. View

13.

Tsao L, Lin J, Wang B, Chang Y, Huang C, Yu S . Long-Term Outcomes of Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy: Critical Appraisal of the Role of Gastric Plication in Bariatric Surgery. Medicina (Kaunas). 2022; 58(9). PMC: 9503388. DOI: 10.3390/medicina58091299. View

14.

Doig G, Simpson F . Randomization and allocation concealment: a practical guide for researchers. J Crit Care. 2005; 20(2):187-91. DOI: 10.1016/j.jcrc.2005.04.005. View

15.

Chiappetta S, De Falco N, Lainas P, Kassir R, Valizadeh R, Kermansaravi M . Safety and efficacy of Roux-en-Y gastric bypass as revisional bariatric surgery after failed anti-reflux surgery: a systematic review. Surg Obes Relat Dis. 2023; 19(11):1317-1325. DOI: 10.1016/j.soard.2023.05.028. View

16.

Eldredge T, Bills M, Ting Y, Dimitri M, Watson M, Harris M . Once in a Bile - the Incidence of Bile Reflux Post-Bariatric Surgery. Obes Surg. 2022; 32(5):1428-1438. PMC: 8883020. DOI: 10.1007/s11695-022-05977-2. View

17.

Varela J, Hinojosa M, Nguyen N . Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease. Surg Obes Relat Dis. 2008; 5(2):139-43. DOI: 10.1016/j.soard.2008.08.021. View

18.

Brasher P, Brant R . Sample size calculations in randomized trials: common pitfalls. Can J Anaesth. 2007; 54(2):103-6. DOI: 10.1007/BF03022005. View

19.

Keleidari B, Mahmoudieh M, Jazi A, Melali H, Nasr Esfahani F, Minakari M . Comparison of the Bile Reflux Frequency in One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Cohort Study. Obes Surg. 2019; 29(6):1721-1725. DOI: 10.1007/s11695-018-03683-6. View

20.

Velanovich V . The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007; 20(2):130-4. DOI: 10.1111/j.1442-2050.2007.00658.x. View